Meet our advisory board

 

  • Sofiat Akinola, Director, Health Policy and External Affairs, Roche Diagnostics
  • Dr. Priya Agrawal, Vice President, Health Equity and Partnerships, MSD International GmbH
  • Dr. Junaid Bajwa, Senior Partner, Flagship Pioneering
  • Dr. Jocalyn Clark, International Editor and Head of Scholarly Comment, The BMJ
  • Helen Gaffney, Partner, Principal Investments, Novo Holdings A/S
  • Amira Ghouaibi, Head, Global Alliance for Women’s Health, World Economic Forum
  • Dr. Sara Saeed Khurram, CEO, Sehat Kahani
  • Oriana Kraft, Founder, FemTechnology
  • Ana-Maria Manda, Global Innovation Management Senior Consultant & SAP's Business Women Network Lead, SAP
  • Misha McKinney, Vice President, National Clinical Programs, Kaiser Permanente
  • Dr. Cora Neumann, Founder, Global First Ladies Alliance
  • Priya Oberoi, General Partner, Goddess Gaia Ventures
  • Will Porteous, Chief Growth Officer, Maven
  • Sara Rico, Senior Customer Success Tech for Social Impact, Microsoft
  • Stephanie Sassman, Portfolio Leader, Women’s Health, Roche Pharma
  • Moz Siddiqui, Director, Partnerships, WHO Foundation
  • Dr. Petra Simic, Medical Director, Bupa Health Clinics
  • Marie Teil, Global Head, Women of Childbearing Age Program, UCB
  • Sahil Tesfu, Chief Strategy Officer, Essity AB
  • Chris Wigley, Co Founder and CEO, Aneira Health
  • Lynsey Willenberg, Healthcare Investor, Mubadala Investment Company

Why we are doing this

Today's women face a number of disadvantages in healthcare, from a lack of funding and research into female diseases to drugs and devices being tested and designed for the male anatomy. The experience of care provided in this unequal healthcare system is leaving women feeling sidelined and inadequately supported.

What we are doing

We have developed a report with players from across the entire healthcare value chain—from pharma companies to payers, providers, academics, investors, start-ups, and nonprofits—that highlights not only the areas of inequity today but also what might be some of the levers and calls to action for specific stakeholders to change things for the better.

2x

42%

80%

Members of the female sex are twice as likely to experience depression and anxiety or develop Alzheimer’s disease.

42% of women have experienced period shaming.

80% of pain medication has been tested only by men or male mice, despite women accounting for 70% of chronic pain patients.

2x
Members of the female sex are twice as likely to experience depression and anxiety or develop Alzheimer’s disease.

42%
42% of women have experienced period shaming.

80%
80% of pain medication has been tested only by men or male mice, despite women accounting for 70% of chronic pain patients.

Meet our community
Click to see the list of leaders who have joined the [w]Health community and are committed to moving the dial on women's health. Together, we will focus on redesigning healthcare with women in mind.